Cogent Biosciences invites an MD oncologist to lead clinical development for bezuclastinib in GIST. You will steer trial design, safety assessment, and data review, collaborating across cross-functional teams to advance our lead molecule through development and lifecycle management.
A strong track record in Phases 2-3 and regulatory interactions is essential. You will interact with sites, CROs, and regulatory agencies, shaping target product profiles and investigative planning in a fast-paced,
#J-18808-Ljbffr